Burnaby – The Government of Canada continues to strengthen Canada’s dynamic industrial capabilities in the life sciences sector. We are expanding domestic biomanufacturing capacity, creating jobs and growing the economy, while also improving our ability to address future health needs and producing the next generation of medicines in our country. Anita Anand, Minister of Innovation, Science and Industry, announced a …
Project will strengthen domestic production of antibody and other protein-based therapies Mississauga – The Government of Canada continues to strive for innovative solutions and prioritize the revitalization of long-term domestic biomanufacturing capacity, positioning Canada at the forefront of antibody therapeutic development. Today, Charles Sousa, Parliamentary Secretary to the Minister of Public Services and Procurement, on behalf of François-Philippe Champagne, Minister …
Laval – In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada. The negotiations began in 2021, during the depths of the COVID-19 pandemic, as the country faced intense global competition to secure vaccines. This global supply chain vulnerability showcased the need to ensure domestic capacity …
